Aurinia Pharmaceuticals I... (AUPH)
NASDAQ: AUPH
· Real-Time Price · USD
8.21
-0.03 (-0.36%)
At close: May 01, 2025, 3:59 PM
8.35
1.71%
After-hours: May 01, 2025, 06:25 PM EDT
Aurinia Pharmaceuticals Revenue
Aurinia Pharmaceuticals reported an annual revenue of $235.13M, reflecting a 33.97% growth. For the quarter ending December 31, 2024, Aurinia Pharmaceuticals generated $59.87M in revenue.
Revenue (ttm)
$235.13M
Revenue Growth
33.97%
Price / Sales Ratio
5.46
Revenue / Employee
$1.81M
Employees
130
Market Cap
1.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 235.13M | +33.97% |
| Dec 31, 2023 | 175.51M | +30.95% |
| Dec 31, 2022 | 134.03M | +193.89% |
| Dec 31, 2021 | 45.6M | -9.00% |
| Dec 31, 2020 | 50.12M | n/a |